Moderna and Metagenomi partner to develop next-gen in vivo gene editing therapeutics
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
Both parties are expected to invest a total of US $ 1 million to establish the brand
The combined entity will have 12 hospitals with 3,666 beds
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
This unique record was made possible by collating hard copies of the books in a structured manner
Key takeaways of recent quarter & conference call highlights
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
Subscribe To Our Newsletter & Stay Updated